Secondary malignant neoplasm of other digestive organs
ICD-10 C78.89 is a billable code used to indicate a diagnosis of secondary malignant neoplasm of other digestive organs.
C78.89 refers to secondary malignant neoplasms that have metastasized to other digestive organs, excluding the liver and pancreas. This condition typically arises from a primary cancer located elsewhere in the body, such as the breast, lung, or colon. The metastatic process involves cancer cells spreading through the bloodstream or lymphatic system to invade other organs. Patients may present with symptoms such as abdominal pain, weight loss, or gastrointestinal disturbances. Diagnosis often involves imaging studies, such as CT scans or MRIs, and may require biopsy for confirmation. Staging of metastatic disease is crucial for treatment planning and prognosis, often utilizing the TNM (Tumor, Node, Metastasis) system. Palliative care considerations are essential, focusing on symptom management and improving quality of life, especially in advanced stages where curative treatment is not feasible.
Detailed history of the primary cancer, staging information, and treatment plans.
Patients with known primary cancers presenting with new gastrointestinal symptoms.
Ensure accurate documentation of metastasis and any palliative care measures taken.
Endoscopic findings, imaging results, and biopsy reports.
Patients with gastrointestinal symptoms and a history of cancer.
Documentation should clearly differentiate between primary gastrointestinal conditions and metastatic disease.
Used for follow-up visits for patients with metastatic disease.
Document history, examination findings, and treatment plan.
Oncology specialists should ensure thorough documentation of cancer history.
Primary malignant neoplasms originate in the organ where they are found, while secondary malignant neoplasms are metastases that have spread from a primary site to another organ.
